Effects of Pooled Platelet Concentrate After Coronary Artery Bypass Graft Surgery in Patients With Dual Antiplatelet

Kaan Kaya1, Ufuk Mungan1

  • 1Department of Cardiovascular Surgery, Lokman Hekim University, School of Medicine, Lokman Hekim Akay Hospital, Ankara, Turkey.

Insights

Pooled platelet concentrate (PPC) significantly reduced postoperative bleeding and hospital stay in patients undergoing coronary artery bypass graft (CABG) surgery after dual antiplatelet therapy (DAPT). This intervention improves patient recovery and comfort.

Area of Science:

  • Cardiovascular Surgery
  • Hematology
  • Anesthesiology

Background:

  • Dual antiplatelet therapy (DAPT) is standard for acute coronary syndrome but increases bleeding risk.
  • Off-pump coronary artery bypass graft (CABG) surgery poses specific challenges for patients on DAPT.
  • Effective strategies to mitigate bleeding complications are crucial in this patient population.

Purpose of the Study:

  • To evaluate the efficacy of pooled platelet concentrate (PPC) in reducing postoperative bleeding.
  • To assess the impact of PPC on blood transfusion requirements and hospital stay.
  • To determine the benefits of PPC in patients undergoing emergent CABG after DAPT loading.

Main Methods:

  • A prospective study included 109 patients undergoing emergent CABG within 24 hours of DAPT loading.
  • Patients were divided into two groups: those receiving PPC during surgery (n=63) and those not (n=46).
  • Postoperative bleeding, need for blood transfusions, surgical revisions, and hospitalization duration were recorded.

Main Results:

  • Group 1 (with PPC) showed significantly less surgical drainage (475.39 mL vs. 679.34 mL, P=.001).
  • No surgical revisions were needed in Group 1 compared to 15.2% in Group 2 (P=.002).
  • Hospital stay was shorter in Group 1 (4 days vs. 6 days, P=.001), with fewer transfusions needed.

Conclusions:

  • Perioperative pooled platelet concentrate (PPC) effectively reduces postoperative bleeding in patients on DAPT undergoing CABG.
  • PPC administration is associated with decreased need for blood products and shorter hospital stays.
  • This intervention enhances early mobilization and patient comfort, improving overall outcomes.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
571
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
12
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
14
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
14
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
16
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K